Market Overview

Jefferies: Procter & Gamble Won't Look Much Better Than This

Share:
Jefferies: Procter & Gamble Won't Look Much Better Than This

Procter & Gamble Co (NYSE: PG) shares suffered a steep stumble through the first four months of the year, but the second quarter saw some long-awaited relief.

Unfortunately, the recovery isn’t expected to last much longer.

The Rating

Jefferies analyst Kevin Grundy downgraded Procter and Gamble to Hold and cut his price target from $83 to $79.

The Thesis

Grundy anticipates challenges to P&G’s market share and top line in 2019. As such, he cut his bottom-line estimate 6.5 percent.

“Our prior constructive thesis had been predicated on an inflection in organic sales,” the analyst wrote in a Monday note. “However, slowing market growth, EM [emerging market] volatility, US retail difficulties, the stronger USD, and pricing challenges should drive estimates lower again at P&G.”

He deemed the stock’s current price “reasonable” and even noted potential for the 18 times price-to-earnings ratio to drop to 17.5 times.

Nonetheless, Jefferies recognizes the distant possibility of improvement. Efforts by activist investor Nelson Peltz, whose Trian holds a seat on the board, could drive strategic changes in the form of a segment sale, restructuring or major merger.

Price Action

Shares closed Monday down 1.8 percent at $77.86.

Related Links:

Argus Cites Disappointing Organic Growth In Procter & Gamble Downgrade

What Is A 'Snake Pit' And Why Should Procter & Gamble Shareholders Care?

Photo courtesy of Procter & Gamble.

Latest Ratings for PG

DateFirmActionFromTo
Jun 2019UpgradesNeutralBuy
Jun 2019MaintainsHold
Apr 2019MaintainsHoldHold

View More Analyst Ratings for PG
View the Latest Analyst Ratings

Posted-In: Jefferies Kevin GrundyAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (PG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PYPLAssumes140.0
VAssumes210.0
WEXAssumes230.0
CRZODowngrades11.0
CIRUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Cresco Labs Creates A New Cannabis Narrative In The Heavily Regulated Cannabis Market

Jason's Picks: Samsung Gear Fit2 Pro Smart Fitness Band